Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy
-
Published:2023-11
Issue:11
Volume:41
Page:458.e1-458.e7
-
ISSN:1078-1439
-
Container-title:Urologic Oncology: Seminars and Original Investigations
-
language:en
-
Short-container-title:Urologic Oncology: Seminars and Original Investigations
Author:
Yim KendrickORCID,
Melnick Kevin,
Mott Sarah L.,
Carvalho Filipe L.F.,
Zafar Affan,
Clinton Timothy N.,
Mossanen Matthew,
Steele Graeme S.,
Hirsch Michelle,
Rizzo Natalie,
Wu Chin-Lee,
Mouw Kent W.,
Wszolek Matthew,
Salari Keyan,
Feldman Adam,
Kibel Adam S.,
O'Donnell Michael A.,
Preston Mark A.